| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CALX | Common Stock | Options Exercise | $148,750 | +25,000 | $5.95* | 25,000 | 15 Nov 2021 | Direct | F1 | |
| transaction | CALX | Common Stock | Sale | $1,813,000 | -25,000 | -100% | $72.52 | 0 | 15 Nov 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CALX | Stock Option (right to buy) | Options Exercise | $0 | -25,000 | -33% | $0.000000 | 50,000 | 15 Nov 2021 | Common Stock | 25,000 | $5.95 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | Shares sold between $70.37 and $74.75 per share at a weighted average price of $72.52. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. |
| F3 | 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. |